Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis?

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (33)

• Abnormal Uterine Bleeding: Medical Treatment with Vaginal Danazol and Five-Year Follow-up via openalex
• A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis via openalex
• A New Therapy for Pelvic Endometriosis and Uterine Adenomyosis: Local Effect of Vaginal and Intrauterine Danazol Application via openalex
• Clinical outcome of vaginal danazol suppository use in women with pelvic endometriosis via openalex
• Clinical Studies with an Antigonadotropin-Danazol via openalex
• Combined use of a long-acting gonadotropin-releasing hormone agonist and low-dose danazol in advanced stage endometriosis via openalex
• Danazol and urogenital sinus formation in pregnancy via openalex
• Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository via openalex
• Danazol for pelvic pain associated with endometriosis via openalex
• Diagnosis, management, and long-term outcomes of rectovaginal endometriosis via openalex
• Dienogest in the treatment of endometriosis via openalex
• Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age via openalex
• Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
• Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain via openalex
• Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device via openalex
• Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis via openalex
• Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany via openalex
• Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone via openalex
• The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis via openalex
• The effects of fetal exposure to danazol via openalex
• Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding via openalex
• Vaginal danazol for the treatment of endometriosis-related pelvic pain via openalex
• Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel‐releasing intrauterine device via openalex
• W6824378097 via openalex
• W188346150 via openalex
• W1618997004 via openalex
• W2046798693 via openalex
• W2067202752 via openalex
• W2110225766 via openalex
• W2133456153 via openalex
• W68155038 via openalex

Cited by (24)

• Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
• Rise and Rise of Endometriosis—An Enigma 2025
• Beyond the surface: Does stage I-II endometriosis impact fertility? Exploring the challenges of mild disease 2024
• Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies 2024
• Medical Treatment of Adenomyosis 2022
• EFFECTIVENESS OF HORMONAL TREATMENT IN PATIENTS WITH COMBINED ENDOMETRIAL PATHOLOGY AND BENIGN FORMATIONS OF MAMMARY GLANDS 2022
• Danazol 2022
• Medical treatments of endometriosis: a review 2022
• Application of Sol–Gels for Treatment of Gynaecological Conditions—Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery 2022
• Treatment of endometriosis: a review with comparison of 8 guidelines 2021
• Observational Study for Adverse Effects and Discontinuation with Long-Term Post-Operative Hormonal Treatment for Endometriosis in Real-World Practice 2021
• Evaluation of the Diagnostic Accuracy of the Interview and Physical Examination in the Diagnosis of Endometriosis as the Cause of Chronic Pelvic Pain 2021
• The role of pharmacotherapy in the treatment of endometriosis across the lifespan 2020
• Pharmacological Treatment of Chronic Pelvic Pain 2020
• Endometriosis Treatment 2020
• Principes thérapeutiques 2020
• Endometriosis 2019
• Endometriosis and pain in the adolescent- striking early to limit suffering: A narrative review 2019
• The role of oxytocin in the pathogenesis of endometriosis: various aspects of the problem 2019
• “Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review 2017
• An Interdisciplinary Approach to Endometriosis-associated Persistent Pelvic Pain 2017
• Role of medical therapy in the management of deep rectovaginal endometriosis 2017
• Revisiting the wandering womb: Oxytocin in endometriosis and bipolar disorder 2017
• Conservative treatment of deep infiltrating endometriosis: review of existing options 2017

Source provenance

europepmc

last seen: 2026-06-04T01:30:01.192114+00:00

openalex

last seen: 2026-06-04T00:00:01.174412+00:00

pubmed

last seen: 2026-05-13T22:17:33.600579+00:00